Sign in to continue:

Wednesday, May 6th, 2026

Hyster-Yale, Inc. Q1 2026 10-Q Report: Financial Statements, Results, and Key Disclosures




Hyster-Yale, Inc. Q1 2026 Financial Report Analysis

Hyster-Yale, Inc. Q1 2026 Financial Results: Key Highlights and Investor Analysis

Overview

Hyster-Yale, Inc. has released its unaudited condensed consolidated financial statements for the first quarter ended March 31, 2026. This report provides a comprehensive look at the company’s performance, financial position, and key metrics that investors and shareholders should closely monitor.

Key Financial Highlights

  • Revenues: Total revenues for Q1 2026 were \$795.2 million, showing a solid top line for the period.
  • Net Income (Loss): The company reported a net loss of (\$30.3 million) for Q1 2026, a significant downturn compared to \$8.7 million net income in the same quarter of the previous year.
  • Operating Income: Operating income for Q1 2026 was \$21.3 million, indicating the company’s ability to generate profit from its core operations despite bottom-line losses.
  • Interest Expense: Interest expense increased to \$7.2 million, up from previous quarters, which could be a concern for future profitability.
  • Income from Unconsolidated Affiliates: The company received \$3.3 million from its equity method investments, contributing positively to the results.
  • Shareholder Dividends: Dividends per share were \$0.3600 for Q1 2026, slightly up from \$0.3500 in Q1 2025.
  • Basic Earnings (Loss) per Share: The company reported basic loss per share of (\$1.71), compared to \$0.49 in Q1 2025.
  • Diluted Earnings (Loss) per Share: Diluted loss per share was also (\$1.71), down from \$0.48 in Q1 2025.
  • Total Assets: At the end of the quarter, total assets stood at \$2,020.6 million.
  • Total Stockholders’ Equity: Equity declined to \$430.1 million, down from \$472.0 million at the end of last year.

Shareholder Information & Potential Price Sensitive Items

  • Significant Net Loss: The company’s shift from profit to a substantial net loss is a noteworthy event and could potentially impact the share price. Investors may react negatively to the (\$30.3 million) loss, especially given the profitable prior year quarter.
  • Dividend Stability: Despite the loss, Hyster-Yale maintained its quarterly dividend, which is a positive signal regarding management’s commitment to shareholder returns. The slight increase in dividend per share may reassure income-focused investors.
  • Declining Equity: The drop in stockholders’ equity signals a weakening financial position and could be seen as a red flag for some investors, especially those focused on balance sheet strength.
  • Rising Interest Expense: The higher interest expense may indicate increased debt levels or higher borrowing costs, which could affect future earnings and cash flows.
  • Cash Flow Concerns: The report details adjustments for non-cash items and dividends, but the underlying net loss could raise questions about future cash flow adequacy and sustainability.
  • Outstanding Shares: As of May 1, 2026, there were 14,471,276 shares of Class A Common Stock and 3,444,626 shares of Class B Common Stock outstanding, affecting dilution and voting power.

Detailed Financial Position

Metric Q1 2026 Q1 2025 / Dec 2025
Revenues \$795.2 million \$812.2 million
Operating Income \$21.3 million \$23.5 million
Net Income (Loss) (\$30.3 million) \$8.7 million
Basic EPS (\$1.71) \$0.49
Diluted EPS (\$1.71) \$0.48
Dividends per Share \$0.3600 \$0.3500
Total Assets \$2,020.6 million \$2,035.6 million
Stockholders’ Equity \$430.1 million \$472.0 million

Comprehensive Income

  • Comprehensive loss attributable to shareholders was (\$39.4 million) for Q1 2026, versus a gain of \$42.2 million in Q1 2025.
  • Accumulated other comprehensive loss stood at (\$6 million), reflecting currency translation and hedge adjustments.

Other Notable Items

  • The company remains a large accelerated filer with all required reports submitted, ensuring compliance and transparency.
  • Trading symbol “HY” on the New York Stock Exchange, with Class A Common Stock as the listed security.
  • There were no defaults upon senior securities or unregistered sales of equity reported in the period.

Conclusion

The Q1 2026 financials present a mixed picture for Hyster-Yale, Inc. While revenues remain robust and dividends steady, the sharp swing to a net loss and decline in equity are concerning for investors. These factors, combined with rising interest expenses, are likely to influence the company’s share price. Investors should closely monitor future earnings releases and management commentary for guidance on recovery prospects.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a financial advisor prior to making any investment decisions. The information presented is based on unaudited financial statements and may be subject to change.




View HYSTER-YALE, INC. Historical chart here



SharonAI Holdings Inc. (SHAZ) Files 8-K Report: Class A Common Stock Listed on NASDAQ as Emerging Growth Company

SharonAI Holdings Inc. Issues Correction Regarding Strategic...

Comstock Inc. 2025 Annual 10-K Report: Business Segments, Investments, and Lease Agreements Overview

Comstock Inc. 2025 Annual Report: Key Insights for Investors...

InMed Pharmaceuticals Reports Pro Forma Financials Following BayMedica Commercial Operations Discontinuation

InMed Pharmaceuticals Announces Pro Forma Financials Reflect...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today